๐ฅ Quant Radar: 2 Healthcare Picks Showing Strong Signals (INCY & RIGL)
As we continue to optimize the portfolio, my latest quantitative screen has flagged two interesting opportunities in the Healthcare sector.
While our portfolio is currently heavy on Financials (~27%) and Tech, adding high-quality healthcare exposure is a key step in our diversification strategy. Here is the data-driven breakdown of why Incyte ($INCY (Incyte Corp.)) and Rigel Pharmaceuticals ($RIGL (Rigel Pharmaceuticals Inc)) are on the watchlist.
1๏ธโฃ Incyte Corp (INCY) โ The "Growth at a Reasonable Price" Play - Large Cap | Biotech โ๏ธ๐ฉป
๐กThe Quant Signal: A "PEG Ratio" of ~0.68.
๐กWhy this matters: In the quant world, a PEG (Price/Earnings-to-Growth) ratio under 1.0 is the gold standard for undervalued growth. It suggests the stock is cheap relative to its future growth potential.
๐งฎ Fundamentals: Incyte recently beat earnings expectations significantly (EPS beat by ~0.61$). With steady revenue growth (~20% YoY) and a forward P/E of ~13-16x, it fits perfectly into our "Value" framework while offering the upside of a biotech growth stock.
๐ฏ Portfolio Fit: A solid, lower-volatility core position to balance our US exposure.
2๏ธโฃ Rigel Pharmaceuticals ($RIGL) โ The "Deep Value" Turnaround- Small Cap | Pharma ๐๐
๐ก The Quant Signal: A P/E Ratio of ~7.1x.
๐ก Why this matters: The sector average is often double or triple this. A P/E this low usually signals a company that is overlooked or "Deep Value."
๐งฎ The Pivot: Rigel has turned the corner into profitability (the "Quality" factor in our model). It has shown massive momentum over the last year (+140% range), driven by strong earnings growth.
๐ฏ Portfolio Fit: This is a higher-risk/higher-reward "Satellite" position. While more volatile than our typical holdings, the valuation buffer (low P/E) provides a margin of safety that aligns with our risk-averse philosophy.
๐ Strategy Impact
Both stocks offer a way to capture Alpha (excess returns) through different factors: INCY through mispriced growth and RIGL through valuation repricing. Including them would lower our correlation to the banking sector and interest rate cycles.
I am monitoring the technical entry points now.
Thoughts on these tickers? Let me know in the comments! ๐... Show More
3
0
0
.
We use our own and third-party cookies on our websites to enhance your experience, analyze traffic, and for security and marketing. For more info, see our Cookie Policy or go to Manage Settings.
Privacy Preference Center
When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.
More information
Manage Consent Preferences
Strictly Necessary Cookies
Always Active
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Cookie List
label
ConsentLeg.Interest
label
label
label
Tue Mar 10 2026 00:35:52 GMT+0000 (Coordinated Universal Time)
